IN2013MU02279A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02279A
IN2013MU02279A IN2279MU2013A IN2013MU02279A IN 2013MU02279 A IN2013MU02279 A IN 2013MU02279A IN 2279MU2013 A IN2279MU2013 A IN 2279MU2013A IN 2013MU02279 A IN2013MU02279 A IN 2013MU02279A
Authority
IN
India
Prior art keywords
vildagliptin
preparation
pure
abstract
formula
Prior art date
Application number
Other languages
English (en)
Inventor
Shriprakash Dhar Dwivedi
Kumar Kamlesh Singh
Nitin Tandon
Shankar Dada Jadhav
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN2279MU2013 priority Critical patent/IN2013MU02279A/en
Publication of IN2013MU02279A publication Critical patent/IN2013MU02279A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2279MU2013 2013-07-05 2013-07-05 IN2013MU02279A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2279MU2013 IN2013MU02279A (fr) 2013-07-05 2013-07-05

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2279MU2013 IN2013MU02279A (fr) 2013-07-05 2013-07-05

Publications (1)

Publication Number Publication Date
IN2013MU02279A true IN2013MU02279A (fr) 2015-07-03

Family

ID=54396525

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2279MU2013 IN2013MU02279A (fr) 2013-07-05 2013-07-05

Country Status (1)

Country Link
IN (1) IN2013MU02279A (fr)

Similar Documents

Publication Publication Date Title
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
IN2013MU03641A (fr)
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
IN2013MU00646A (fr)
MX362879B (es) Usos novedosos.
MA40313A (fr) Composition pharmaceutique à base d'isotrétinoïne destinée à la voie orale
MX2020009444A (es) Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion.
GEP201706626B (en) Synthesis of (s)-nifuratel
MX2015003034A (es) Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso.
MA40312A (fr) Composition pharmaceutique orale d'isotrétinoïne
IN2013MU01113A (fr)
MX2015016603A (es) Composiciones de corticosteroides.
IN2013MU01111A (fr)
IN2013MU04056A (fr)
UA116994C2 (uk) Стабілізована аморфна форма агомелатину, спосіб її одержання і фармацевтичні композиції, які її містять
PH12015502703A1 (en) Pharmaceutical compositions
IN2013CH04314A (fr)
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
IN2013MU03317A (fr)
IN2013MU02528A (fr)
IN2013MU02279A (fr)
IN2013MU03768A (fr)
IN2014DN07498A (fr)
IN2013CH05770A (fr)
IN2013CH05769A (fr)